Correlation Between Shenzhen Bioeasy and Meinian Onehealth

Can any of the company-specific risk be diversified away by investing in both Shenzhen Bioeasy and Meinian Onehealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Bioeasy and Meinian Onehealth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shenzhen Bioeasy Biotechnology and Meinian Onehealth Healthcare, you can compare the effects of market volatilities on Shenzhen Bioeasy and Meinian Onehealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Bioeasy with a short position of Meinian Onehealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Bioeasy and Meinian Onehealth.

Diversification Opportunities for Shenzhen Bioeasy and Meinian Onehealth

0.64

Correlation Coefficient

Shenzhen Bioeasy  Meinian Onehealth

Poor diversification

The 3 months correlation between Shenzhen and Meinian is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Bioeasy Biotechnology and Meinian Onehealth Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meinian Onehealth and Shenzhen Bioeasy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Bioeasy Biotechnology are associated (or correlated) with Meinian Onehealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meinian Onehealth has no effect on the direction of Shenzhen Bioeasy i.e., Shenzhen Bioeasy and Meinian Onehealth go up and down completely randomly.

Pair Corralation between Shenzhen Bioeasy and Meinian Onehealth

Assuming the 90 days trading horizon Shenzhen Bioeasy is expected to generate 2.69 times less return on investment than Meinian Onehealth. In addition to that, Shenzhen Bioeasy is 1.59 times more volatile than Meinian Onehealth Healthcare. It trades about 0.02 of its total potential returns per unit of risk. Meinian Onehealth Healthcare is currently generating about 0.08 per unit of volatility. If you would invest  397.00  in Meinian Onehealth Healthcare on October 23, 2024 and sell it today you would earn a total of  43.00  from holding Meinian Onehealth Healthcare or generate 10.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Shenzhen Bioeasy Biotechnology  vs.  Meinian Onehealth Healthcare

Shenzhen Bioeasy Bio

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Shenzhen Bioeasy is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Meinian Onehealth

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Meinian Onehealth Healthcare are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meinian Onehealth may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Shenzhen Bioeasy and Meinian Onehealth

The main advantage of trading using opposite Shenzhen Bioeasy and Meinian Onehealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Bioeasy position performs unexpectedly, Meinian Onehealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meinian Onehealth will offset losses from the drop in Meinian Onehealth's long position.

The idea behind Shenzhen Bioeasy Biotechnology and Meinian Onehealth Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.